Skip to content
‹ Back to IndustriesHealthcare

Verified, Tested, Trusted: How Corganics Ensures THC-Free Confidence in Clinical CBD

Corganics develops THC-free, medical-grade CBD products exclusively for healthcare professionals, supported by FDA-registered manufacturing and Advanced Lipid Technology. The company prioritizes rigorous third-party testing and transparency to meet clinical standards rarely found in the broader CBD market. President Reggie Gatewood discusses how these practices build trust and confidence among medical providers.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Corganics on MarketScale.

By Corganics · · Beauty Base Zero Aesthetics & WellnessBrooke WilliamsClinical CbdCorganics
Share

Key takeaways

01

Corganics produces THC-free, medical-grade CBD formulated exclusively for healthcare professional use.

02

Products are manufactured in FDA-registered facilities and validated through rigorous third-party testing.

03

Advanced Lipid Technology enhances bioavailability and consistency in Corganics' cannabinoid formulations.

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Corganics is redefining standards in clinical cannabinoid care with THC-free, medical-grade CBD products developed for use exclusively by healthcare professionals. Backed by Advanced Lipid Technology, FDA-registered manufacturing, and rigorous third-party testing, Corganics offers a level of trust and transparency rare in the CBD space.

In a conversation with Reggie Gatewood, President of Corganics, Brooke Williams, DNP, CRNA, APNP, and founder of Beauty Base Zero Aesthetics & Wellness, asked how providers and patients can be confident there’s truly no THC in the products. Gatewood explained that while hemp and marijuana are related, Corganics uses hemp and a precise extraction process to reduce THC to non-detectable levels—far below legal limits.

Every product includes a QR code linking to full third-party lab results, verifying both purity and safety. These reports confirm the absence of THC, heavy metals, solvents, and pesticides. It’s this level of clinical validation that positions Corganics as the trusted CBD solution recommended by top professionals across wellness and aesthetic medicine.

By combining transparency, safety, and physician-advised formulation, Corganics removes the stigma around CBD and delivers products healthcare providers can confidently stand behind.

Corganics

Part of this channel

Corganics

Medical-grade CBD products developed with healthcare professionals.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

C
Corganics
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Harbor Health to buy 27 Village Medical clinics in Greater Houston

Harbor Health to buy 27 Village Medical clinics in Greater Houston

Harbor Health's purchase of Village Medical clinics in Houston is expected to close at the end of 2026. The 27 clinics are the primary care home for Harbor members in four counties.

  • 01Harbor's $0 specialist benefit only applies when a Harbor clinician makes the referral. For Houston employers, the test is whether employees will use the 27 clinics as their first stop.

Oct 8, 2026

SCI recruits funeral sales as the career AI cannot replace

SCI recruits funeral sales as the career AI cannot replace

SCI's recruiting video positions funeral and cremation sales as a career resistant to automation by emphasizing the human trust required in end-of-life planning. The pitch frames the role as requiring both compassion and sales drive, targets people outside the industry, and leans on demographic demand from an aging population to argue for job stability.

  • 01More than 11,000 Americans turn 65 daily, SCI says demand will grow.
  • 02SCI seeks candidates with dual traits: compassion and empathy alongside sales-oriented drive and tenacity.
  • 03The role requires no prior industry experience; SCI provides training, coaching, and technology to prepare newcomers.

Oct 7, 2026

CURORI Details Readiness Framework for Planned Ten-City Expansion in China

CURORI, a China-based medical-aesthetic coordination platform founded in 2025, has outlined a readiness framework to expand its city coverage from five to ten Chinese destinations by the end of 2027. The expansion will be phased around provider and service readiness rather than destination count alone, with review areas including qualified doctors, licensed institutions, procedure categories, communication processes, and practical factors for international users.

  • 01CURORI plans to expand from five currently served cities (Beijing, Shanghai, Guangzhou, Shenzhen, Hangzhou) to ten by December 31, 2027, with Chengdu, Xi'an, Wuhan, and two additional locations under evaluation.
  • 02The company's readiness framework requires operational checks across provider qualifications, licensed institutions, procedure availability, assessment requirements, communication processes, quotation clarity, appointment coordination, and follow-up arrangements before launching in new cities.
  • 03CURORI has a separate objective to help reduce client costs by approximately 10% by the end of 2026 through comparison, clearer quotation information, free initial coordination, and future incentives.

Oct 7, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Experts

C
Corganics

President, Corganics

Reggie Gatewood is President of Corganics, a company focused on medical-grade CBD products for healthcare professionals. He oversees the development and distribution of THC-free cannabinoid products backed by FDA-registered manufacturing and third-party testing. Gatewood is an advocate for transparency and clinical standards in the cannabinoid industry.

BW
Brooke Williams

Brooke Williams appears in the Corganics conversation alongside Reggie Gatewood, discussing the company's clinical CBD standards and THC-free product line. Further professional details are not confirmed from available sources.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512